Congenital stromal corneal dystrophy

Congenital stromal corneal dystrophy (CSCD), is an extremely rare, autosomal dominant form of corneal dystrophy.<ref name=audcscd>,
Congenital stromal dystrophy of the cornea caused by a mutation in the decorin gene, Invest Ophthalmol Vis Sci, Vol. 46(Issue: 2), pp. 420–426, DOI: 10.1167/iovs.04-0804, PMID: 15671264, Full text,
</ref> Only 4 families have been reported to have the disease by 2009.<ref name="pmid19236704">Klintworth GK,
Corneal dystrophies, Orphanet J Rare Dis, 2009, Vol. 4, pp. 7, DOI: 10.1186/1750-1172-4-7, PMID: 19236704, PMC: 2695576, Full text,</ref> The main features of the disease are numerous opaque flaky or feathery areas of clouding in the stroma that multiply with age and eventually preclude visibility of the endothelium. Strabismus or primary open angle glaucoma was noted in some of the patients. Thickness of the cornea stays the same, Descemet's membrane and endothelium are relatively unaffected, but the fibrills of collagen that constitute stromal lamellae are reduced in diameter and lamellae themselves are packed significantly more tightly.
Genetics
CSCD is associated with a mutation in the gene DCN that encodes the protein decorin, located at chromosome 12q22.<ref name=audcscd/> The disorder is inherited in an autosomal dominant manner,<ref name=audcscd/> which indicates that the defective gene responsible for a disorder is located on an autosome (chromosome 12 is an autosome), and only one copy of the gene is sufficient to cause the disorder, when inherited from a parent who has the disorder.
Diagnosis
This section is empty. You can help by adding to it. (July 2017) |
Treatment
This section is empty. You can help by adding to it. (July 2017) |
References
External links
Template:Human corneal dystrophy
| Diseases of collagen, laminin and other scleroproteins | ||||||
|---|---|---|---|---|---|---|
see also fibrous proteins
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
